Skip to main content

Advertisement

SpringerLink
Log in

Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

The purpose of the study was to assess effects of the competitive N-methyl-D-aspartate (NMDA) receptor antagonist D-(E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid (D-CPPene) upon focal cerebral infarction and brain oedema in the rat. Focal cerebral ischaemia was produced by permanent occlusion of the middle cerebral artery under halothane anaesthesia. The anaesthetic gas was discontinued immediately after the occlusion and the rats were killed 24 hours later. Cerebral infarction and brain swelling were each assessed on the frozen brain sections at 8 predetermined coronal planes.

Pretreatment with D-CPPene (4.5mg/kg i.v. followed by continuous infusion at 3mg/kg/h until sacrifice) 15 minutes prior to MCA occlusion, significantly reduced the volume of infarction in the cerebral hemisphere by 29% (p<0.05). Brain swelling, obtained by subtracting the nonischaemic hemispheric volume from the ischaemic hemispheric volume, was significantly reduced with D-CPPene treatment and the mean reduction in swelling (34% less than the controls: p<0.001) proportionately similar to the decrease in infarct volume in the same animals.

These data indicate that systemic administration of the competitive NMDA receptor antagonist D-CPPene has neuroprotective effects against ischaemic brain damage, and the reduction in brain swelling occurs in parallel with the reduction in ischaemic damage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aebischer B, Frey P, Haerter H-P, Herrling PL, Mueller W (1989) 115. Synthesis and NMDA antagonist properties of the enantiomers of 4-(3-phosphonopropyl) piperazine-2-carboxylic acid (CPP) and of the unsaturated analogue (E)-4-(3-phosphonoprop-2-enyl)piperazine-2-carboxylic acid (CPP-ene). Helv Chim Acta 72: 1043–1051

    Google Scholar 

  2. Anderson RE, Michenfelder JD, Sundt TM (1980) Brain intracellular pH, blood flow, and blood-brain barrier differences with barbiturate and halothane anesthesia in the cat. Anesthesiology 52: 201–206

    PubMed  Google Scholar 

  3. Baethmann A, Oettinger W, Rothenfußer W, Kempski O, Unterberg A, Geiger R (1980) Brain edema factors: current state In: Cervos-Navarro J, Ferszt R (eds) Advances in neurology, Vol 28. Raven, New York, pp 171–195

    Google Scholar 

  4. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski HM (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472–476

    PubMed  Google Scholar 

  5. Buchan AM, Slivka A, Xue D (1992) The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res 574: 171–177

    PubMed  Google Scholar 

  6. Buchan AM, Xue D, Slivka A, Zhang C, Hamilton J, Gelb A (1989) MK-801 increases cerebral blood flow in a rat model of temporary focal cortical ischemia. Soc Neurosci Abstr 15: 804

    Google Scholar 

  7. Bullock R, Graham DI, Chen MH, Lowe D, McCulloch J (1990) Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene. J Cereb Blood Flow Metab 10: 688–674

    Google Scholar 

  8. Chen M, Bullock R, Graham DI, Frey P, Lowe D, McCulloch J (1991) Evaluation of a competitive NMDA antagonist (D-CCPene) in feline focal cerebral ischemia. Ann Neurol 30: 62–70

    PubMed  Google Scholar 

  9. Forster A, Van Horn K, Marshall LF, Shapiro HM (1978) Anesthetic effects on blood-brain barrier function during acute arterial hypertension. Anesthesiology 49: 26–30

    PubMed  Google Scholar 

  10. George CP, Goldberg MP, Choi DW, Steinberg GK (1988) Dextromethorphan reduces neocortical ischemic neuronal damage in vivo. Brain Res 440: 375–379

    PubMed  Google Scholar 

  11. Germano IM, Pitts LH, Meldrum BS, Bartkowski HM, Simon RP (1987) Kynurenate inhibition of cell excitation decreases stroke size and deficits. Ann Neurol 22: 730–734

    PubMed  Google Scholar 

  12. Gotti B, Duverger D, Bertin J, Carter C, Dupont R, Frost J, Gaudillier B, MacKengie ET, Rousseau J, Scatton B, Wick A (1988) Ifenprodil and SL 82.0715 as cerebral anti-ischemic chemia. J Pharmacol Exp Ther 247: 1211–1221

    PubMed  Google Scholar 

  13. Jacewicz M, Brint S, Tanabe J, Pulsinelli WA (1990) Continuous nimodipine treatment attenuates cortical infarction in rats subjected to 24 hours of focal cerebral ischemia. J Cereb Blood Flow Metab 10: 89–96

    PubMed  Google Scholar 

  14. Keaney NP, Pickerodt VW, McDowall DG, Coroneos NJ, Turner JM, Shah ZP (1973) Cerebral circulatory and metabolic effects of hypotension produced by deep halothane anaesthesia. J Neurol Neurosurg Psychiatry 36: 898–905

    PubMed  Google Scholar 

  15. König JFR, Klippel RA (1963) In the rat brain: a stereotaxic atlas of the forebrain and lower parts of the brain stem. Krieger, New York

    Google Scholar 

  16. Kurumaji A, McCulloch J (1989) Effects of MK-801 upon local anaesthetised with halothane. J Cereb Blood Flow Metab 9: 786–794

    PubMed  Google Scholar 

  17. Kurumaji A, Nehls DG, Park CK, McCulloch J (1989) Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use. Brain Res 492: 268–284

    Google Scholar 

  18. Kusumoto K, Mackay KB, McCulloch J (1992) The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischemia. Brain Res 576: 147–151

    PubMed  Google Scholar 

  19. Lowe DA, Neijt HC, Aebischer B (1990) D-CPP-ene (SDZ EAA 494), a potent and competitive N-methyl-D-aspartate (NMDA) antagonist: effect on spontaneous activity and NMDA-induced depolarizations in the rat neocortical slice preparation, compared with other CPP derivatives and MK-801. Neurosci Lett 113: 315–321

    PubMed  Google Scholar 

  20. Mohamed AA, Gotoh O, Graham DI, Osborne KA, McCulloch J, Mendelow AD, Teasdale GM, Harper AM (1985) Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 18: 705–711

    PubMed  Google Scholar 

  21. McCulloch J, Bullock R, Teasdale GM (1991) Excitatory amino acid antagonists: opportunities for the treatment of ischemic brain damage in man. In: Meldrum BS (ed) Excitatory amino acid antagonists. Blackwell Edinburgh, pp 287–327

    Google Scholar 

  22. Mrsulja BB, Stanimirovic D, Micic DV, Spatz M (1990) Exitatory amino acid receptors, oxido-reductive processes and brain oedema following transient ischaemia in gerbils. Acta Neurochir (Wien) [Suppl] 51: 180–182

    Google Scholar 

  23. Nehls DG, Kurumaji A, Park CK, McCulloch J (1988) Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system. Neurosci Lett 23: 204–210

    Google Scholar 

  24. Nitsch C, Goping G, Klatzo I (1986) Pathophysiological aspects Schwarcz R, Ben-Ari Y (eds) Excitatory amino acids and epilepsy. Plenum, New York, pp 175–189

    Google Scholar 

  25. Osborne KA, Shigeno T, Ford I, McCulloch J, Teasdale GM, Graham DI (1987) Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia J Neurol Neurosurg Psychiatry 50: 402–410

    PubMed  Google Scholar 

  26. Ott EO, Mathew NT, Meyer JS (1974) Redistribution of regional cerebral blood flow after glycerol infusion in acute cerebral infarction. Neurology 24: 1117–1126

    PubMed  Google Scholar 

  27. Oyzurt E, Graham DI, Woodruff GN, McCulloch J (1988) The protective effect of the glutamate antagonist MK-801 in focal cerebral ischaemia in the cat. J Cereb Blood Flow Metab 8: 138–143

    PubMed  Google Scholar 

  28. Park CK, McCulloch J, Kang JK, Choi CR (1992) Efficacy of D-CPPene, a competitive N-methyl-D-aspratate antagonist in focal cerebral ischemia in the rat. Neursci Lett 147: 41–44

    Google Scholar 

  29. Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J (1988) Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia. J Cereb Blood Flow Metab 8: 757–762

    PubMed  Google Scholar 

  30. Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J (1988) The glutamate antagonist MK-801 reduces focal ischaemic brain damage in the rat. Ann Neurol 24: 543–551

    PubMed  Google Scholar 

  31. Park CK, Nehls DG, Teasdale GM, McCulloch J (1989) Effects of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 9: 617–622

    PubMed  Google Scholar 

  32. Persson L, Hardemark H-G, Bolander HG, Hillered L, Olsson Y (1989) Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats. Stroke 20: 640–645

    Google Scholar 

  33. Rothman SM, Olney JW (1986) Glutamate and pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19: 105–111

    PubMed  Google Scholar 

  34. Sauer D, Nuglisch J, Rossberg C, Mennel H-D, Beck T, Bielenberg GW, Krieglstein J (1988) Phencyclidine reduces postischemic neuronal necrosis in rat hippocampus without changing blood flow. Neurosci Lett 91: 327–332

    PubMed  Google Scholar 

  35. Simon R, Shiraishi K (1990) N-methyl-D-aspartate antagonist reduces stroke size and regional glucose metabolism. Ann Neurol 27: 606–611

    PubMed  Google Scholar 

  36. Simon RP, Swan JH, Griffiths T, Meldrum BS (1984) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226: 850–883

    Google Scholar 

  37. Simon RP, Young RSK, Stout S, Cheng J (1986) Inhibition of excitatory neurotransmission with kynurenate reduces brain edema in neonatal anoxia. Neurosci Lett 71: 361–364

    PubMed  Google Scholar 

  38. Sperk G, Lassmann H, Baran H, Kish SJ, Seitelberger F, Hornykiewicz O (1983) Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 10: 1301–1315

    PubMed  Google Scholar 

  39. Steinberg GK, George CP, DeLaPaz RD, Shibata DK, Gross T (1988) Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits. Stroke 19: 1112–1118

    PubMed  Google Scholar 

  40. Takizawa S, Hogan M, Hakim AM (1991) The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia. J Cereb Blood Flow Metab 11: 786–793

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Catholic University Medical College, Seoul, Korea

    C. K. Park M.D., J. McCulloch, J. K. Kang & C. R. Choi

Authors
  1. C. K. Park M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. McCulloch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. K. Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. R. Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, C.K., McCulloch, J., Kang, J.K. et al. Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats. Acta neurochir 127, 220–226 (1994). https://doi.org/10.1007/BF01808770

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01808770

Keywords

Search

Navigation